# Role of MMP-2, MMP-9, TIMP-1, and TIMP-2 in children with ventricular septal defect

**Authors:** Nina Maric, Ines Mrakovcic Sutic, Jelica Predojevic Samardzic, Dario Djukic, Aleksandar Bulog, Ivana Sutic

PMC · DOI: 10.17305/bb.2024.11162 · Biomolecules and Biomedicine · 2024-10-17

## TL;DR

This study explores how certain proteins in urine can predict the development and closure of heart defects in children.

## Contribution

The study introduces a non-invasive urine-based method to assess VSD using MMPs and TIMPs concentrations.

## Key findings

- MMP-2, MMP-9, TIMP-1, and TIMP-2 concentrations are significantly higher in children with VSD.
- MMP-9 levels are significantly higher in children with VSD that does not close spontaneously.
- Urinary concentrations of these proteins correlate with the size of the heart defect.

## Abstract

Ventricular septal defect (VSD) is the second most common congenital heart anomaly. In most cases, it closes spontaneously in the first year of life, but it sometimes requires surgical closure due to the risk of serious complications. This is why it is important to identify markers that could help predict its course. Findings that matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play an important role in the cleavage of the extracellular matrix were the reasons to investigate their role in cardiogenesis. In prior studies on this topic, their concentrations were studied in the blood. The aim of this prospective study was to investigate the role of MMP-2, MMP-9, TIMP-1, and TIMP-2 in the etiology and pathophysiology of VSD using urine samples, as an innovative non-invasive approach, and the enzyme-linked immunosorbent assay (ELISA) method. It involved 52 children with isolated VSD and 20 healthy children up to one year of age. We found that these MMPs and TIMPs are significantly (P ═ 0.000) higher in children with VSD, and the correlations between their concentrations and the size of the defect are positive, especially for MMP-9 and TIMP-1. MMP-9 was significantly (P ═ 0.044) higher in cases in which VSD did not close in the first year of life compared to cases in which it closed. Our results suggest the role of MMP-2, MMP-9, TIMP-1, and TIMP-2 in the aetiopathogenesis of VSD and that their urinary concentrations, especially of MMP-9, in combination with echocardiographic and clinical monitoring, could be useful in predicting its natural course.

## Linked entities

- **Proteins:** MMP2 (matrix metallopeptidase 2), MMP9 (matrix metallopeptidase 9), TIMP1 (TIMP metallopeptidase inhibitor 1), TIMP2 (TIMP metallopeptidase inhibitor 2)
- **Diseases:** ventricular septal defect (MONDO:0002070), VSD (MONDO:0002070)

## Full-text entities

- **Genes:** MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, TIMP2 (TIMP metallopeptidase inhibitor 2) [NCBI Gene 7077] {aka CSC-21K, DDC8}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}
- **Diseases:** congenital heart anomaly (OMIM:600001), VSD (MESH:D006345)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12097395/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12097395/full.md

## References

63 references — full list in the complete paper: https://tomesphere.com/paper/PMC12097395/full.md

---
Source: https://tomesphere.com/paper/PMC12097395